Markus Muschen Selected Research

Markus Muschen Research Topics

5	Leukemia 01/2020 - 05/2011
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 05/2011
3	Neoplasms (Cancer) 10/2021 - 10/2015
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2022 - 10/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2011

2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 04/2022 - 10/2021
2	Casein Kinase II (Casein Kinase 2)IBA 01/2020 - 10/2015
2	DNA (Deoxyribonucleic Acid)IBA 06/2017 - 10/2015
1	LB100IBA 10/2021
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 10/2021
1	atezolizumabIBA 10/2021
1	Carboplatin (JM8)FDA LinkGeneric 10/2021
1	silmitasertibIBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 06/2017
1	DNA-Activated Protein KinaseIBA 06/2017
1	Pharmaceutical PreparationsIBA 11/2016
1	Biomarkers (Surrogate Marker)IBA 11/2016
1	Therapeutic UsesIBA 10/2015
1	Pre-B Cell ReceptorsIBA 11/2012
1	KW 2449IBA 05/2011
1	entinostat (MS 275)IBA 05/2011
1	Histone Deacetylase InhibitorsIBA 05/2011
1	Phosphotransferases (Kinase)IBA 05/2011
1	Imatinib Mesylate (Gleevec)FDA Link 05/2011
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2011
1	Vorinostat FDA Link 05/2011
1	Aurora KinasesIBA 05/2011